116 related articles for article (PubMed ID: 10052755)
1. Associations between amino acids in the evolution of HIV type 1 protease sequences under indinavir therapy.
Brown AJ; Korber BT; Condra JH
AIDS Res Hum Retroviruses; 1999 Feb; 15(3):247-53. PubMed ID: 10052755
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy.
Sa-Filho DJ; Costa LJ; de Oliveira CF; Guimarães AP; Accetturi CA; Tanuri A; Diaz RS
J Clin Virol; 2003 Oct; 28(2):186-202. PubMed ID: 12957189
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir.
Côté HC; Brumme ZL; Harrigan PR
J Virol; 2001 Jan; 75(2):589-94. PubMed ID: 11134271
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies.
Ibáñez A; Clotet B; Martínez MA
J Gen Virol; 2000 Jan; 81(Pt 1):85-95. PubMed ID: 10640545
[TBL] [Abstract][Full Text] [Related]
5. A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure.
Stürmer M; Staszewski S; Doerr HW; Hertogs K
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):967-8. PubMed ID: 14678603
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.
Zhang YM; Imamichi H; Imamichi T; Lane HC; Falloon J; Vasudevachari MB; Salzman NP
J Virol; 1997 Sep; 71(9):6662-70. PubMed ID: 9261388
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure.
Sangeda RZ; Theys K; Beheydt G; Rhee SY; Deforche K; Vercauteren J; Libin P; Imbrechts S; Grossman Z; Camacho RJ; Van Laethem K; Pironti A; Zazzi M; Sönnerborg A; Incardona F; De Luca A; Torti C; Ruiz L; Van de Vijver DA; Shafer RW; Bruzzone B; Van Wijngaerden E; Vandamme AM;
Infect Genet Evol; 2013 Oct; 19():349-60. PubMed ID: 23523594
[TBL] [Abstract][Full Text] [Related]
8. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.
Condra JH; Holder DJ; Schleif WA; Blahy OM; Danovich RM; Gabryelski LJ; Graham DJ; Laird D; Quintero JC; Rhodes A; Robbins HL; Roth E; Shivaprakash M; Yang T; Chodakewitz JA; Deutsch PJ; Leavitt RY; Massari FE; Mellors JW; Squires KE; Steigbigel RT; Teppler H; Emini EA
J Virol; 1996 Dec; 70(12):8270-6. PubMed ID: 8970946
[TBL] [Abstract][Full Text] [Related]
9. Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group.
Pieniazek D; Rayfield M; Hu DJ; Nkengasong J; Wiktor SZ; Downing R; Biryahwaho B; Mastro T; Tanuri A; Soriano V; Lal R; Dondero T
AIDS; 2000 Jul; 14(11):1489-95. PubMed ID: 10983635
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil.
Tanuri A; Vicente AC; Otsuki K; Ramos CA; Ferreira OC; Schechter M; Janini LM; Pieniazek D; Rayfield MA
Antimicrob Agents Chemother; 1999 Feb; 43(2):253-8. PubMed ID: 9925514
[TBL] [Abstract][Full Text] [Related]
11. Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.
Gianotti N; Tambussi G; Boeri E; Lazzarin A
J Biol Regul Homeost Agents; 2001; 15(2):166-9. PubMed ID: 11501975
[TBL] [Abstract][Full Text] [Related]
12. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
13. Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitors.
Shafer RW; Hsu P; Patick AK; Craig C; Brendel V
J Virol; 1999 Jul; 73(7):6197-202. PubMed ID: 10364383
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 hypersusceptibility to amprenavir in vitro can be associated with virus load response to treatment in vivo.
Zachary KC; Hanna GJ; D'Aquila RT
Clin Infect Dis; 2001 Dec; 33(12):2075-7. PubMed ID: 11700580
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.
Bally F; Martinez R; Peters S; Sudre P; Telenti A
AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1209-13. PubMed ID: 10957718
[TBL] [Abstract][Full Text] [Related]
16. Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333.
Sevin AD; DeGruttola V; Nijhuis M; Schapiro JM; Foulkes AS; Para MF; Boucher CA
J Infect Dis; 2000 Jul; 182(1):59-67. PubMed ID: 10882582
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].
Mouroux M; Bossi P; Yvon-Groussin A; Delaugerre C; Valantin MA; Tubiana R; Coutellier A; Bonmarchand M; Bricaire F; Katlama C; Agut H; Huraux JM; Calvez V
Pathol Biol (Paris); 1999 May; 47(5):549-52. PubMed ID: 10418038
[TBL] [Abstract][Full Text] [Related]
18. Profiling resistance-related mutations in the protease region of the pol gene: single genome sequencing of HIV in plasma and peripheral blood mononuclear cells.
Guimarães AP; Sa-Filho DJ; Sucupira MC; Janini LM; Diaz RS
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):969-71. PubMed ID: 18593345
[TBL] [Abstract][Full Text] [Related]
19. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Nájera R; Pumarola T; Alonso-Socas Mdel M; García-Bujalance S; Menéndez-Arias L;
J Med Virol; 2007 Nov; 79(11):1617-28. PubMed ID: 17854027
[TBL] [Abstract][Full Text] [Related]
20. Indinavir resistance evolution in one human immunodeficiency virus type 1 infected patient revealed by single-genome amplification.
Geng QM; Li HP; Bao ZY; Liu YJ; Zhuang DM; Li L; Liu SY; Li JY
Virol Sin; 2010 Oct; 25(5):316-28. PubMed ID: 20960178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
